| Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma (NCT05116878) | Mayo Clinic | 2021-11-01 |
| Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 (NCT04351373) | Mayo Clinic | 2021-10-06 |
| Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma (NCT04859335) | University Hospital, Toulouse | 2021-05-21 |
| Nimodipine in Vestibular Schwanommas (NCT04801953) | Medical University of Vienna | 2021-05-04 |
| MR Fingerprinting for Vestibular Schwannomas (NCT04851925) | Medical University of Vienna | 2021-02-24 |
| Vestibular Precision: Physiology & Pathophysiology (NCT04890132) | Massachusetts Eye and Ear Infirmary | 2020-07-01 |
| Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) (NCT04374305) | Scott R. Plotkin, MD, PhD | 2020-06-20 |
| Vestibular Schwannoma Organoids (NCT05786144) | Maastricht Radiation Oncology | 2020-06-01 |
| Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF (NCT04658836) | Medical University of Vienna | 2020-02-01 |
| Auditory Nerve Test System During Vestibular Schwannoma Resection (NCT04241679) | Washington University School of Medicine | 2020-01-20 |
| Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy (NCT04594057) | University of Utah | 2019-12-10 |
| Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma (NCT04196933) | Massachusetts Eye and Ear Infirmary | 2019-09-05 |
| Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas (NCT04057976) | King's College Hospital NHS Trust | 2019-06-27 |
| Novel Multimodality Imaging for Navigation in Skull Base Surgery (NCT04128345) | University College, London | 2019-05-01 |
| CI Following VS Removal or Labyrinthectomy (NCT03795675) | Ohio State University | 2019-01-14 |
| Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma (NCT03958006) | Henry Ford Health System | 2018-12-05 |
| Vegetative Monitoring During Brainstem-associated Surgery (NCT03666507) | University Hospital Tuebingen | 2018-08-28 |
| Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study (NCT03745534) | Christoph Arnoldner | 2018-08-01 |
| Study of Aspirin in Patients With Vestibular Schwannoma (NCT03079999) | Massachusetts Eye and Ear Infirmary | 2018-06-11 |
| Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI (NCT03593577) | University Hospital, Strasbourg, France | 2018-06-01 |
| Consequence of Unilateral Vestibular Loss on Visual Abilities (NCT03581331) | Assistance Publique Hopitaux De Marseille | 2018-02-26 |
| Protocol for Evaluating a Planning Algorithm for Gamma Knife Radiosurgery (NCT03520829) | Assistance Publique Hopitaux De Marseille | 2018-01-10 |
| WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data (NCT03210285) | University Hospital Tuebingen | 2017-07-31 |
| Intraoperative EABR for Decision Making (NCT03745560) | Christoph Arnoldner | 2017-05-23 |
| Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (NCT03095248) | Children's Hospital Medical Center, Cincinnati | 2017-05-08 |
| Vestibular Outcomes in Vestibular Schwannoma (NCT03346889) | Haukeland University Hospital | 2017-04-23 |
| Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (NCT02934256) | Li Peng | 2016-07-01 |
| Role of Psychiatric Profile in Prehabituated Patients After Vestibular Schwannoma Surgery (NCT03638310) | Charles University, Czech Republic | 2016-01-01 |
| Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma (NCT02282917) | Massachusetts Eye and Ear Infirmary | 2015-12-01 |
| Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function (NCT02415257) | Lund University | 2015-04-01 |
| Preoperative Vestibular Rehabilitation Effectiveness After Vestibular Schwannoma Surgery (NCT02275325) | Central Hospital, Nancy, France | 2015-01-01 |
| Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function (NCT02379754) | Lund University | 2015-01-01 |
| Vestibular Schwannoma - Radiosurgery or Expectation: V-REX. (NCT02249572) | Haukeland University Hospital | 2014-10-01 |
| Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma (NCT02963896) | University Hospital, Motol | 2014-01-01 |
| Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study (NCT01938677) | Karolinska Institutet | 2013-04-01 |
| Vestibular Schwannoma and Psychological Factors (NCT01743248) | Central Hospital, Nancy, France | 2012-08-01 |
| Stereotactic Radiation in Vestibular Schwannoma (NCT01449604) | Ramathibodi Hospital | 2011-10-01 |
| Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma (NCT01083966) | Northwell Health | 2011-08-01 |
| Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma (NCT01199978) | Massachusetts General Hospital | 2011-03-08 |
| Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) (NCT01207687) | National Cancer Institute (NCI) | 2010-10-01 |
| Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (NCT00973739) | NYU Langone Health | 2009-09-01 |
| Concentration and Activity of Lapatinib in Vestibular Schwannomas (NCT00863122) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-06-01 |